BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
526
Block Inc
XYZ
$49.9B
| $18.1M | 0.03% |
288,772
+102,375
| +55% | +$6.54M |
|
527
Aflac
AFL
$60.7B
| $18M | 0.03% |
341,013
-208,280
| -38% | -$11.1M |
|
528
Intuit
INTU
$98B
| $18M | 0.03% |
68,852
-35,681
| -34% | -$9.33M |
|
529
Universal Health Services
UHS
$10.1B
| $17.9M | 0.03% |
124,851
+24,477
| +24% | +$3.49M |
|
530
DexCom
DXCM
$34.5B
| $17.9M | 0.03% |
327,348
+194,448
| +146% | +$9.22M |
|
531
CALL
Dollar General
DG
$26.9B
| $17.9M | 0.03% |
1,145
+176
| +18% | +$27.9K |
|
|
ALXN
532
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $17.9M | 0.03% |
1,651
+1,571
| +1,964% | +$168K |
|
533
CALL
Morgan Stanley
MS
$343B
| $17.8M | 0.03% |
3,488
+1,948
| +126% | +$92.2K |
|
534
iShares MSCI Mexico ETF
EWW
$1.87B
| $17.8M | 0.03% |
394,858
+49,710
| +14% | +$2.21M |
|
535
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $17.6M | 0.03% |
173,089
-1,511,184
| -90% | -$145M |
|
536
VF Corp
VFC
$5.79B
| $17.6M | 0.03% |
176,554
+110,422
| +167% | +$9.9M |
|
|
RTN
537
PUT
DELISTED
Raytheon Company
RTN
| $17.6M | 0.03% |
799
-52
| -6% | -$11K |
|
|
MRO
538
DELISTED
Marathon Oil Corporation
MRO
| $17.5M | 0.03% |
1,289,502
-160,426
| -11% | -$1.96M |
|
539
OGE Energy
OGE
$9.71B
| $17.4M | 0.03% |
391,828
+172,318
| +79% | +$7.44M |
|
540
VeriSign
VRSN
$26B
| $17.4M | 0.03% |
90,416
-7,909
| -8% | -$1.49M |
|
541
CALL
Eli Lilly
LLY
$1.08T
| $17.4M | 0.03% |
1,324
+284
| +27% | +$32.9K |
|
542
CALL
PepsiCo
PEP
$192B
| $17.4M | 0.03% |
1,271
-1,105
| -47% | -$150K |
|
543
Pinnacle West Capital
PNW
$12.2B
| $17.3M | 0.03% |
192,154
-132,968
| -41% | -$12M |
|
|
IPG
544
DELISTED
Interpublic Group of Companies
IPG
| $17.2M | 0.03% |
744,867
+636,039
| +584% | +$14M |
|
545
Lumen
LUMN
$6.6B
| $17.2M | 0.03% |
1,301,143
+345,384
| +36% | +$4.63M |
|
546
PUT
Ulta Beauty
ULTA
$22.2B
| $17.2M | 0.03% |
678
+84
| +14% | +$20.5K |
|
547
Capital One
COF
$137B
| $17.1M | 0.03% |
166,252
-102,269
| -38% | -$9.86M |
|
548
Paychex
PAYX
$44.6B
| $17.1M | 0.03% |
201,001
-5,306
| -3% | -$448K |
|
549
PUT
CSX Corp
CSX
$92.9B
| $17M | 0.03% |
7,035
+720
| +11% | +$17K |
|
|
GRMN
550
Garmin
GRMN
$60.2B
| $17M | 0.03% |
173,862
+38,685
| +29% | +$3.61M |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.